MO32-4 A real-world multicentre retrospective study of low-dose apatinib for HER2-negative metastatic breast cancer
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI